DOC in type I lepra reaction with severe neuritis –
**Core Concept**
Type I lepra reaction, also known as an erythema nodosum leprosum (ENL) reaction, is a severe, immune-mediated complication of leprosy characterized by the sudden onset of painful skin nodules, joint inflammation, and nerve damage. This reaction is a result of the body's immune response to the leprosy bacillus, Mycobacterium leprae.
**Why the Correct Answer is Right**
The drug of choice (DOC) in the management of Type I lepra reaction with severe neuritis is corticosteroids, specifically prednisolone. Corticosteroids work by suppressing the immune system's overactive response and reducing inflammation in the affected nerves. This is crucial in preventing permanent nerve damage and improving symptoms.
**Why Each Wrong Option is Incorrect**
* **Option A:** Thalidomide is not the first-line treatment for Type I lepra reaction with severe neuritis, although it may be used in some cases. Thalidomide has anti-inflammatory and immunomodulatory effects but is associated with significant side effects.
* **Option B:** Clofazimine is an antimicrobial agent used in the treatment of leprosy but is not the DOC for Type I lepra reaction. Clofazimine has anti-inflammatory properties but is not as effective as corticosteroids in managing severe neuritis.
* **Option D:** Chloroquine is an antimalarial agent with some anti-inflammatory effects but is not the preferred treatment for Type I lepra reaction with severe neuritis.
**Clinical Pearl / High-Yield Fact**
In patients with Type I lepra reaction, it's essential to initiate corticosteroid therapy promptly to prevent permanent nerve damage. The dosage of corticosteroids should be tapered gradually once the reaction is controlled to minimize side effects.
**Correct Answer: C. Prednisolone. Corticosteroids.**